NO953420D0 - Oxa- or thialiphatic bridge-containing chinoxaline-2,3-dione - Google Patents

Oxa- or thialiphatic bridge-containing chinoxaline-2,3-dione

Info

Publication number
NO953420D0
NO953420D0 NO953420A NO953420A NO953420D0 NO 953420 D0 NO953420 D0 NO 953420D0 NO 953420 A NO953420 A NO 953420A NO 953420 A NO953420 A NO 953420A NO 953420 D0 NO953420 D0 NO 953420D0
Authority
NO
Norway
Prior art keywords
thialiphatic
chinoxaline
oxa
dione
bridge
Prior art date
Application number
NO953420A
Other languages
Norwegian (no)
Other versions
NO953420L (en
Inventor
Robert Moretti
Kaspar Zimmermann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO953420D0 publication Critical patent/NO953420D0/en
Publication of NO953420L publication Critical patent/NO953420L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO953420A 1994-09-01 1995-08-31 Oxa- or tialiphatic bridge-containing quinoxaline-2-dione NO953420L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH268094 1994-09-01
CH40295 1995-02-09

Publications (2)

Publication Number Publication Date
NO953420D0 true NO953420D0 (en) 1995-08-31
NO953420L NO953420L (en) 1996-03-04

Family

ID=25684470

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953420A NO953420L (en) 1994-09-01 1995-08-31 Oxa- or tialiphatic bridge-containing quinoxaline-2-dione

Country Status (12)

Country Link
EP (1) EP0705835A1 (en)
JP (1) JPH08109185A (en)
KR (1) KR960010651A (en)
CN (1) CN1133844A (en)
AU (1) AU3028795A (en)
BR (1) BR9503876A (en)
CA (1) CA2157231A1 (en)
FI (1) FI954072A (en)
HU (1) HUT73436A (en)
IL (1) IL115103A0 (en)
NO (1) NO953420L (en)
NZ (1) NZ272888A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063774A (en) * 1996-12-16 2000-05-16 Warner-Lambert Company Tricyclic quinoxaline derivatives as neuroprotective agents
US6288075B1 (en) 1998-02-26 2001-09-11 Rhone-Poulenc Rorer S.A. Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
FR2760237B1 (en) * 1997-02-28 1999-04-16 Rhone Poulenc Rorer Sa THIAZOLOBENZOHETEROCYCLES, THEIR PREPARATION AND THE MEDICINES CONTAINING THEM
FR2766487B1 (en) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa THIAZOLOBENZOHETEROCYCLES, THEIR PREPARATION AND THE MEDICINES CONTAINING THEM
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
ES2656017T3 (en) 2004-06-24 2018-02-22 Vertex Pharmaceuticals Incorporated Conveyor modulators of the ATP binding cassette
DK3219705T3 (en) 2005-12-28 2020-04-14 Vertex Pharma PHARMACEUTICAL COMPOSITIONS OF THE AMORPHIC FORM OF N- [2,4-BIS (1,1-DIMETHYLETHYL) -5-HYDROXYPHENYL] -1,4-DIHYDRO-4-OXOQUINOLIN-3-CARBOXAMIDE
EP3330255B1 (en) 2009-03-20 2020-12-09 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
AU2013226076B2 (en) 2012-02-27 2017-11-16 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof
JP6746569B2 (en) 2014-10-07 2020-08-26 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK715888D0 (en) * 1988-12-22 1988-12-22 Ferrosan As QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE
DK716188D0 (en) * 1988-12-22 1988-12-22 Ferrosan As QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE
ES2067744T3 (en) * 1989-06-09 1995-04-01 Upjohn Co HETEROCICLIC AMINES WITH ACTIVITY ON THE CENTRAL NERVOUS SYSTEM.
JPH05117276A (en) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd New tricyclic quinoxalinedione derivative
ES2313714T3 (en) * 1992-06-22 2009-03-01 The Regents Of The University Of California ANTIGONISTS OF GLYCINE RECEPTORS AND USE OF THE SAME.
EP0664807B1 (en) * 1992-10-13 1997-09-10 Warner-Lambert Company Quinoxalinedione derivatives as eaa antagonists
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones

Also Published As

Publication number Publication date
HU9502562D0 (en) 1995-10-30
KR960010651A (en) 1996-04-20
NZ272888A (en) 1997-05-26
IL115103A0 (en) 1995-12-08
HUT73436A (en) 1996-07-29
JPH08109185A (en) 1996-04-30
NO953420L (en) 1996-03-04
CN1133844A (en) 1996-10-23
AU3028795A (en) 1996-03-14
FI954072A0 (en) 1995-08-30
EP0705835A1 (en) 1996-04-10
FI954072A (en) 1996-03-02
CA2157231A1 (en) 1996-03-02
BR9503876A (en) 1996-09-17

Similar Documents

Publication Publication Date Title
NL1000839C1 (en) Lantern.
NL1000830C1 (en) Lantern.
BR9700688A (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones
BR9707786B1 (en) compound.
ATE221526T1 (en) 2-HETAROYLCYCLOHEXANE-1,3-DIONE
FI970438A0 (en) Foerfarande i panna, saerskilt i sodapanna
TR199500945A1 (en) Substituted biphenyloxazolines.
DE59814019D1 (en) 2-benzoyl-cyclohexane-1,3-DIONE
NO953420D0 (en) Oxa- or thialiphatic bridge-containing chinoxaline-2,3-dione
DE69504283D1 (en) Wavelength converter
DK0874814T3 (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferoler
FI1592U1 (en) Spruta, foeretraedesvis injectionspruta
FR2716049B1 (en) Converter.
DE59510943D1 (en) 2-Arylcyclopentan-1,3-dione derivatives
ES1032571Y (en) GAFA,
ATE231848T1 (en) SUBSTITUTED 2-BENZOYL-CYCLOHEXANE-1,3-DIONE
IT234659Y1 (en) SOTTOSELLA.
DE59510660D1 (en) Wavelength converter
FR2720962B1 (en) Baguetteuse.
FR2714950B3 (en) Reducer-variator.
FR2720961B1 (en) Baguetteuse.
ES1028811Y (en) INTEGRAL GARMENT-SHOE.
FI944648A0 (en) Bromsmekanism Foer fordon, saerskilt Foer en cykel
FIU940180U0 (en) Baotstege, kaerra, landgaong
FI945785A0 (en) Pimpelspoe, fiskeredokap